In vitro activity of cefoperazone-sulbactam: Singapore experience
Affiliations
- PMID: 9253876
Item in Clipboard
In vitro activity of cefoperazone-sulbactam: Singapore experience
Southeast Asian J Trop Med Public Health.
1996 Dec.
Abstract
In vitro activity of commonly used antimicrobial agents against consecutively isolated 521 strains of Gram negative bacilli causing serious infections in the National University Hospital, Singapore were tested in parallel with cefoperazone-sulbactam combination. With the combination complete resistance of 2% and intermediate resistance of 5% were noted among the 521 strains tested. Resistance to imipenem was low (5%) but resistance against other antimicrobial agents varied from 12% (amikacin) to 80% (ampicillin). In vitro data demonstrated a possible future role for cefoperazone-sulbactam in the treatment of sepsis caused by Gram negative bacilli in our hospital.
Similar articles
-
In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.Malays J Pathol. 1995 Dec;17(2):73-6. Malays J Pathol. 1995. PMID: 8935129
-
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.Int J Antimicrob Agents. 2004 Jun;23(6):590-5. doi: 10.1016/j.ijantimicag.2003.10.008. Int J Antimicrob Agents. 2004. PMID: 15194130
-
In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.Nepal Med Coll J. 2012 Mar;14(1):5-8. Nepal Med Coll J. 2012. PMID: 23441486
-
The current state of multidrug-resistant gram-negative bacilli in North America.Pharmacotherapy. 2008 Feb;28(2):235-49. doi: 10.1592/phco.28.2.235. Pharmacotherapy. 2008. PMID: 18225969 Review.
-
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.Clin Infect Dis. 1997 Mar;24(3):494-7. doi: 10.1093/clinids/24.3.494. Clin Infect Dis. 1997. PMID: 9114205 Review.
MeSH terms
Substances
LinkOut - more resources
Medical